DOJ: Covenant Healthcare paid $69M in 2021 false claims settlement
By 
Adrianne Appel2023-03-30T17:58:00
A Michigan hospital system paid $69 million to settle whistleblower allegations it engaged in illegal referral and kickback schemes.
Covenant Healthcare System rented office space to a physician but forgave the rent in exchange for the physician referring Medicare patients to the hospital system in violation of the federal Anti-Kickback Statute, the Department of Justice (DOJ) said in a press release Wednesday.
Covenant also allegedly employed physicians, including Mark Adams and Asim Yunus, between 2006 and 2016 who self-referred patients to Covenant in violation of the federal Physician Self-Referral Law. Also known as the Stark Law, the rule aims to prevent doctors from steering Medicare patients to facilities in which they have a financial interest.
THIS IS MEMBERS-ONLY CONTENT
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
Related articles
-
News BriefS.C.-based St. Francis to pay $36.5M in false claims settlement
South Carolina-based healthcare system St. Francis agreed to pay $36.5 million as part of a settlement with the Department of Justice addressing alleged violations of the False Claims Act, Stark Law, and Anti-Kickback Statute.
-
News BriefSibley Hospital, Johns Hopkins to pay $5M for improper billing
Sibley Hospital and its parent company, Johns Hopkins Health System, agreed to pay $5 million to settle allegations the hospital billed Medicare for services referred by physicians with whom it had a financial relationship.
-
News BriefGenotox Laboratories to pay $5.9M in DOJ kickback settlement
Genotox Laboratories agreed to pay at least $5.9 million to settle charges it violated the False Claims Act by paying volume-based commissions to third-party marketers and submitting claims to federal healthcare programs for unnecessary drug tests.
More from Regulatory Enforcement
-
ArticleU.K. competition regulator ‘very likely’ to use new enforcement powers despite government’s pro-growth agenda
New powers granted to the U.K.’s main competition watchdog will result in greater scrutiny, tougher enforcement, and a stark warning for companies to review their sales and marketing promotions—especially since some practices have been pushed firmly into the spotlight thanks to legislation that came into effect last year.
-
ArticleSEC enforcement priorities revert back to basics
Recent pronouncements made by the U.S. Securities and Exchange Commission leadership, alongside the recent overhaul of the SEC Enforcement Manual, collectively signal a back-to-basics enforcement approach that appears beneficial for companies in their dealings with the agency.
-
ArticleFCA drive to reduce its investigation costs likely to add to compliance burden for smaller firms, warn experts
The U.K. financial regulator’s move towards “impactful deterrence” could see smaller and mid-size firms come increasingly under the spotlight as the watchdog aims to tackle market-wide concerns instead of primarily focusing on large players capable of doing the most harm.